PCRX R&D to Revenue
Pacira Biosciences Inc · R&D to Revenue
PCRX R&D to Revenue
Latest reported16.15%period ending
PCRX FY R&D/Revenue (238.52% → 16.15%)
Latest values, visible window
High-resolution chart · PNG
PCRX r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 16.1495% | |
| 11.6378% | |
| 11.2977% | |
| 12.7166% | |
| 10.257% | |
| 13.8302% | |
| 17.1293% | |
| 16.5111% | |
| 19.9874% | |
| 16.5278% | |
| 11.511% | |
| 9.476% | |
| 25.2013% | |
| 25.4247% | |
| 94.7989% | |
| 127.922% | |
| 174.8167% | |
| 238.5206% |